Page last updated: 2024-12-07
3-methyl-1-phenyltriazene
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 85248 |
| CHEMBL ID | 121569 |
| SCHEMBL ID | 9119900 |
| SCHEMBL ID | 22263150 |
| MeSH ID | M0074868 |
Synonyms (27)
| Synonym |
|---|
| 1-triazene, 1-methyl-3-phenyl- |
| 3-methyl-1-phenyltriazine |
| wln: 1mnunr |
| triazene, 3-methyl-1-phenyl- |
| nsc-136056 |
| nsc136056 |
| 3-methyl-1-phenyltriazene |
| 1-phenyl-3-monomethyltriazene |
| 1-phenyl-3-monomethyl-triazene |
| 16033-21-9 |
| phenylmonomethyltriazene |
| triazene, 3-monomethyl-1-phenyl- |
| pmmt |
| methylphenyltriazene |
| 1-methyl-3-phenyltriazene |
| triazene, 1-methyl-3-phenyl- |
| 1-phenyl-3-methyltriazine |
| nsc 136056 |
| CHEMBL121569 |
| SCHEMBL9119900 |
| n-(methyldiazenyl)aniline |
| AKOS006279617 |
| 1-phenyl-3-methyltriazene |
| 1-methyl-3-phenyl-1-triazene |
| DTXSID50166862 |
| phenyl-mono-methyl-triazen |
| SCHEMBL22263150 |
Research Excerpts
Toxicity
Bioassays (3)
| Assay ID | Title | Year | Journal | Article |
|---|
| AID24514 | In vitro biological stability and half-life was measured in phosphate buffer at a pH of 7.4 at 37 degree Centigrade | 1984 | Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
| Studies of the mode of action of antitumor triazenes and triazines. 6. 1-Aryl-3-(hydroxymethyl)-3-methyltriazenes: synthesis, chemistry, and antitumor properties. |
| AID1132822 | Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase of host lifespan | 1978 | Journal of medicinal chemistry, Jun, Volume: 21, Issue:6
| Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice. |
| AID1148445 | Half life of the compound at pH 7.4 at 37 degC in presence of serum | 1978 | Journal of medicinal chemistry, Jun, Volume: 21, Issue:6
| Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 2. On the role of correlation analysis in decision making in drug modification. Toxicity quantitative structure-activity relationships of 1-(X-phenyl)-3,3-dialkyltriazenes in mice. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.09
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.09 (24.57) | | Research Supply Index | 2.20 (2.92) | | Research Growth Index | 4.28 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |